In parallel, studies in breast cancer patients found an association between leptin and ObR overexpression with a chronic inflammatory status, conditioning T-cell immune responses (increase Th1- and decrease Th2-responses) (34) and the activation of immune checkpoint inhibitors (29). The gene discussed is LEP; the disease is breast carcinoma.